BOSTON SCIENTIFIC CORPORATION AXIOS STENT AND ELECTROCAUTERY ENHANCED DELIVERY SYSTEM; PANCREATIC STENT, COVERED, METALLIC, REMOVABLE
|
Back to Search Results |
|
Model Number M00553530 |
Device Problem
Activation Failure (3270)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 02/16/2023 |
Event Type
malfunction
|
Event Description
|
It was reported to boston scientific corporation that an axios stent and electrocautery enhanced delivery system was to be implanted transduodenal to the bile duct during a bile drainage procedure performed on (b)(6) 2023.During the procedure, the stent first flange did not expand.The axios stent was removed from the patient partially deployed, and another device was used to complete the procedure.There were no patient complications as a result of this event.The patient's condition at the conclusion of the procedure was reported to be good.
|
|
Manufacturer Narrative
|
H6: imdrf device code a150101 captures the reportable event of stent first flange failure to expand.
|
|
Manufacturer Narrative
|
Block h6: imdrf device code a150101 captures the reportable event of stent first flange failure to expand.Block h10: an axios stent and electrocautery enhanced delivery system were received for analysis.The stent was received fully deployed and expanded.Visual examination of the returned device found the inner sheath kinked.A dimensional inspection was performed, and the stent was measured to be within specification.No other problems were noted with the stent and delivery system.The investigation concluded that the observed problem of inner sheath kinked was likely due to factors encountered during the procedure.It may be that lesion characteristics, handling of the device and the technique used by the physician (force applied), limited the performance of the device and contributed to the observed problem.The reported event of stent first flange failure to expand cannot be confirmed as the stent was received fully deployed and expanded.Based on the available information, there is not enough information to confirm the reported event of stent first flange failure to expand; therefore, a review and analysis of all available information indicated the most probable cause is no problem detected.A labeling review was performed and, from the information available, this device was used per the instructions for use (ifu) / product label.
|
|
Event Description
|
It was reported to boston scientific corporation that an axios stent and electrocautery enhanced delivery system was to be implanted transduodenal to the bile duct during a bile drainage procedure performed on (b)(6) 2023.During the procedure, the stent first flange did not expand.The axios stent was removed from the patient partially deployed, and another device was used to complete the procedure.There were no patient complications as a result of this event.The patient's condition at the conclusion of the procedure was reported to be good.
|
|
Search Alerts/Recalls
|
|
|